In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate Biomarkers
Takefumi Kikuchi(Sapporo Medical University), David P. Carbone(Vanderbilt University), Qinfeng Liu(Hunan Normal University), Lisa J. Zimmerman(Unknown), Jacob M. Kaufman(Vanderbilt University), Pierre P. Massion(Vanderbilt University), Yu Shyr(Vanderbilt University), D.C. Liebler(National Institute of Standards and Technology), S.M. Jamshedur Rahman(Vanderbilt University), Xueqiong Zhang(Peking University), Ming Li(Central South University), Adriana L. Gonzalez(Vanderbilt University), Mohamed Hassanein(Pfizer (United States)), Megan D. Hoeksema(Vanderbilt University), Robbert J.C. Slebos(University of Iowa), Joseph M. Amann(The Ohio State University), Bradford K. Harris(Vanderbilt University)
Cited by 76
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k